<DOC>
	<DOCNO>NCT01097330</DOCNO>
	<brief_summary>Implantable Cardioverter Defibrillators ( ICDs ) provide shock pace therapy bring back normal heart beat patient experience dangerous abnormal heart rhythm ventricular tachycardia ( VT ) . ICDs successful bring back normal heart beat VT occur , prevent dangerous heart rhythm occur . This study design determine best way manage patient ICD continue episode VT . There two method treatment VT : 1 ) Ablation , 2 ) Medication . An ablation procedure involve place flexible catheter ( insulated wire ) groin area thread heart . After doctor locate affected area responsible VT , radiofrequency energy deliver power generator catheter inside heart . The radiofrequency energy ablates ( burn ) small area heart tissue think cause VT. A medication call Amiodarone `` anti-arrhythmic '' prescribe prevent abnormal heart rhythm recur . The purpose study compare two different method treat VT . Treatment ablation amiodarone consider standard care patient VT compare directly study like .</brief_summary>
	<brief_title>Catheter Ablation Versus Amiodarone Shock Prophylaxis Defibrillator Patients With Ventricular Tachycardia</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Inclusion Criteria Patients must meet following criterion : &gt; 18 &lt; 85 year age ICD implant primary prophylaxis sudden cardiac death ICD implant secondary prophylaxis spontaneous inducible sustain VT without reversible cause CAD prior MI ICD ECG documentation ventricular arrhythmia responsible appropriate ICD therapy [ ATP &amp; shock ] . Exclusion Criteria Patients follow criterion : Contraindication allergy contrast medium , routine procedural medication catheter material Contraindication interventional procedure Current previous ( within 3 month ) amiodarone therapy Atrial Fibrillation require antiarrhythmic drug therapy Contraindication amiodarone therapy New York Heart Association ( NYHA ) functional class IV Myocardial infarction within past 60 day Stroke within past 90 day Unstable angina Hypertrophic cardiomyopathy , Nonischemic dilate cardiomyopathy , Arrhythmogenic Right Ventricular Dysplasia , Brugada Syndrome , Catecholamine sensitive polymorphic VT long QT syndrome Patients active ischemia eligible revascularization Life expectancy le 6 month Incessant multiple episode VT require immediate therapy medication ablation Untreated hypothyroidism hyperthyroidism . Patients euthyroid thyroid hormone replacement therapy acceptable . Current enrollment another investigational drug device study . Presence condition investigator feel would problematic would restrict limit participation patient entire study period . Absolute contraindication use heparin warfarin . Documented intraatrial thrombus , ventricular thrombus ( &lt; 6 month detection thrombus ) , tumor , another abnormality preclude catheter introduction . Females childbearing potential practicing protocol acceptable method birth control .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Defibrillators , Implantable</keyword>
	<keyword>Tachycardia , Ventricular</keyword>
	<keyword>Catheter Ablation</keyword>
	<keyword>Amiodarone</keyword>
</DOC>